← Back to Clinical Trials
Recruiting NCT07438522

NCT07438522 Isometric and Isotonic Hand Strengthening in Competitive Female Badminton Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07438522
Status Recruiting
Phase
Sponsor Riphah International University
Condition Athletic Performance and Injury Risk
Study Type INTERVENTIONAL
Enrollment 32 participants
Start Date 2025-12-01
Primary Completion 2026-08-01

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 30 Years
Study Type INTERVENTIONAL
Interventions
Isometric hand strengthening programIsotonic hand strengthening program

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 32 participants in total. It began in 2025-12-01 with a primary completion date of 2026-08-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This randomized clinical trial aims to determine the effects of targeted isometric and isotonic hand strengthening exercises on hand function, dexterity, grip strength and grip endurance in competitive female badminton athletes aged 18-30 years. Participants will be randomly allocated into two groups receiving either isometric or isotonic hand strengthening exercise programs performed three times per week for six weeks. Outcome measures will be assessed at baseline, 3rd week and 6th week using Michigan Hand Outcomes Questionnaire (MHQ), Purdue Pegboard Test or Nine-Hole Peg Test, Hand Dynamometer Test and Sustained Grip Test.

Eligibility Criteria

Inclusion Criteria: * Female badminton athletes * Age between 18-30 years * Right-hand dominant * Minimum 2 years of competitive badminton experience Exclusion Criteria: * History of upper limb injury in last 6 months * Cardiovascular or metabolic disorder limiting exercise * Medication affecting muscle performance * Current upper limb rehabilitation program participation

Contact & Investigator

Central Contact

Danish Hassan, PhD

✉ danish.hassan009@gmail.com

📞 +92 345 7946009

Principal Investigator

Danish Hassan, PhD

PRINCIPAL INVESTIGATOR

Riphah International University

Frequently Asked Questions

Who can join the NCT07438522 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 30 Years, studying Athletic Performance and Injury Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07438522 currently recruiting?

Yes, NCT07438522 is actively recruiting participants. Contact the research team at danish.hassan009@gmail.com for enrollment information.

Where is the NCT07438522 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT07438522 clinical trial?

NCT07438522 is sponsored by Riphah International University. The principal investigator is Danish Hassan, PhD at Riphah International University. The trial plans to enroll 32 participants.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology